LongBio Pharma shines in Hong Kong debut; Lung Fung, Dajin fall
BUZZ-LongBio Pharma shines in Hong Kong debut; Lung Fung, Dajin fall ** Shares of LongBio Pharma (Suzhou) 1779.HK jump as much as 64.5% from offer price to HK$158 each in HK debut, bucking a 0.8% dip in benchmark Hang Seng Index .HSI
** Stock last trading at HK$139 by lunch break, up 44.7% from offer price
** Chinese developer of biopharmaceuticals sold 14.19 mln shares in global offering, raising HK$1.36 bln ($173.63 mln) for R&D and commercialization of products
** HK public offering portion 4,762.58 times subscribed, international offering 10.94 times subscribed
** Shares of Lung Fung Group 2290.HK drop 35.3% to as low as HK$3.35 in HK debut after beauty, health and pharmaceuticals products retailer raised HK$647.5 mln in global offering
** Lung Fung sold 125 mln shares at HK$5.18, with public and international offering subscribed 664.92 times and 3.18 times, respectively
** Shares of Dajin Heavy Industry 1081.HK fall 11.1% in HK debut after HK$6.64 bln share sale. Stock last trading at HK$63.1, down 5% from HK$66.40 offer price
($1 = 7.8329 Hong Kong dollars)
(Reporting by Donny Kwok)